Milwaukee-based blood health and research organization Versiti on Monday announced its acquisition of Quantigen, a specialty lab in Fishers, Indiana.

Founded as an expert methods development laboratory, Quantigen provides a range of services supporting preclinical research as well as clinical diagnostics and is expected to expand Versiti’s clinical trial expertise and service offerings, a press release states.

The Quantigen team specializes in assay development, biomarker validation, and diagnostic regulatory filings for a wide range of methods and disease states. The laboratory has ongoing partnerships with NGOs to adapt existing diagnostic technologies for use in lower- and middle-income countries to address significant unmet diagnostic and health needs in these communities, according Versiti.

Click here to read the full article.